Pharmacological Targeting of the Ephrin Receptor Kinase Signalling by GLPG1790 in Vitro and in Vivo Reverts Oncophenotype, Induces Myogenic Differentiation and Radiosensitizes Embryonal Rhabdomyosarcoma Cells
Journal of Hematology and Oncology - United Kingdom
doi 10.1186/s13045-017-0530-z
Full Text
Open PDFAbstract
Available in full text
Date
October 6, 2017
Authors
Publisher
Springer Science and Business Media LLC